Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Amgen drug shows high response rate in small lung, colon cancer trial

      Amgen drug shows high response rate in small lung, colon cancer trial

      Medical Dialogues Bureau14 Jun 2019 9:15 AM IST
      Wall Street has taken a keen interest in the Amgen drug that could become the first approved medicine targeting a mutated form of a gene known as KRAS...
      Canadian advisory council calls for universal public drug coverage

      Canadian advisory council calls for universal public drug coverage

      Medical Dialogues Bureau14 Jun 2019 9:00 AM IST
      The council said a national drug agency should be created first, with coverage for essential medicines in place by January 1, 2022.OTTAWA: A Canadian...
      Novartis

      Novartis' secret settlement talks revealed in accidental filing: Bloomberg Report

      Medical Dialogues Bureau13 Jun 2019 10:03 AM IST
      The U.S. sued the Novartis six years ago, joining in a case filed by a former sales representative who accused the company of using its speaker's...
      Reckitt Benckiser names PepsiCo executive Laxman Narasimhan as next CEO

      Reckitt Benckiser names PepsiCo executive Laxman Narasimhan as next CEO

      Medical Dialogues Bureau13 Jun 2019 9:30 AM IST
      Laxman Narasimhan (52) would join RB as CEO-designate and then would be appointed to the board of the company as an Executive Director with effect...
      Emerging drug DS-8201 could soon spell end of chemotherapy: Report

      Emerging drug DS-8201 could soon spell end of chemotherapy: Report

      Medical Dialogues Bureau13 Jun 2019 9:15 AM IST
      As importantly, its ability to target cancer cells without affecting normal cells is a key advantage over the take-no-prisoners approach of...
      Catalyst Pharma files lawsuit against USFDA challenging approval of Ruzurgi

      Catalyst Pharma files lawsuit against USFDA challenging approval of Ruzurgi

      Medical Dialogues Bureau13 Jun 2019 9:00 AM IST
      Ruzurgi was approved last month for treating Lambert-Eaton myasthenic syndrome that affects about one in 100,000 people in the United States.U.S:...
      Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer

      Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer

      Medical Dialogues Bureau12 Jun 2019 9:50 AM IST
      The approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
      Eye care chain Disha Medical Services raises over Rs 27 crore in Series C funding

      Eye care chain Disha Medical Services raises over Rs 27 crore in Series C funding

      Medical Dialogues Bureau12 Jun 2019 9:45 AM IST
      Exiting investor Lok advised fund - Sarva Capital has been provided with a full exit as part of the current fundraising, Disha Medical Services said...
      Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

      Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

      Medical Dialogues Bureau12 Jun 2019 9:30 AM IST
      Roche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
      Cipla receives inspection report from USFDA for Kurkumbh facility

      Cipla receives inspection report from USFDA for Kurkumbh facility

      Medical Dialogues Bureau11 Jun 2019 12:02 PM IST
      The Kurkumbh manufacturing facility was inspected by the United States Food and Drug Administration (USFDA) from March 11 to March 20, 2019, Cipla...
      Roche gets USFDA nod for combo lymphoma treatment Polivy

      Roche gets USFDA nod for combo lymphoma treatment Polivy

      Medical Dialogues Bureau11 Jun 2019 9:30 AM IST
      Polivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
      Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20

      Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20

      Medical Dialogues Bureau11 Jun 2019 9:15 AM IST
      The growth would primarily better revenues from its drug Copaxone as projected by Natco Pharma's marketing partner Mylan and also improved performance...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok